Posts with tag Pharmaceuticals

This article is part of our series covering the proposed reforms to the EU pharmaceutical legislation. To view the entire series, click here. Overview of the Key Changes to Regulatory Data Protection One of the primary changes—and the focus of considerable debate—is the revision of the rules regarding regulatory data protection. The new Directive's draft text devotes an entire chapter to regulatory data and market protection. You can read our initial article on the Commission’s...